Financial Information

Consolidated Balance Sheet

Assets(¥ million)
115th period 116th period
Month of Settlement March 2019 March 2020
Current Assets 32,430 33,421
Fixed Assets 27,899 26,331
Breakdown Tangible fixed Assets 22,399 20,808
Tangible fixed Assets 333 473
Tangible fixed Assets 5,165 5,049
Total Assets 60,329 59,752
Liabilities(¥ million)
115th period 116th period
Month of settlement March 2019 March 2020
Current liabilities 17,462 14,175
Fixed Liabilities 6,386 8,358
Total liabilities 23,848 22,533
Net Assets(¥ million)
115th period 116th period
Settlement Date March 2019 March 2020
Stockholders' Equity 35,193 36,158
Breakdown Capital 5,451 5,451
Capital Surplus 4,186 4,186
Retained Earnings 25,570 26,534
Treasury Stock △15 △15
Accumulated Other Comprehensive Income 1,287 1,060
Breakdown Valuation Difference on Other Securities 239 129
Foreign Currency Translation Adjustment Account △65 △28
Accumulated Adjustment for Retirement Benefits 1,113 959
Total Net Assets 36,480 37,218
Total Liabilities and Net Assets 60,329 59,752

Consolidated Statement of Income

(¥ million)
115th period 116th period
Month of settlement March 2019 March 2020
Net sales 47,417 44,063
Cost of sales 31,992 29,182
Gross profit 15,425 14,880
Selling, general and administrative expenses 11,741 11,905
Other income 238 208
Other expenses 62 88
Ordinary income 3,860 3,095
Extraordinary income 965 190
Extraordinary loss 272 798
Income before income taxes 4,553 2,487
Income taxes-deferred 1,359 669
Net income 3,193 1,751
Net income attributable to non-controlling shareholders - -
Net income attributable to owners of parent 3,193 1,751

Consolidated Cash Flow

(¥ million)
115th period 116th period
Month of settlement March 2019 March 2020
Cash flows from operating activities 5,584 5,776
Cash flows from investing activities △4,743 △1,408
Cash flows from financing activities △979 △916
Exchange differences on cash and cash equivalents △2 △1
Change in cash and cash equivalents △140 3,450
Cash and cash equivalents at beginning of year 7,963 7,822
Cash and cash equivalents at end of year 7,822 11,273

Capital Investment and Depreciation

Share this page

IR Support